POU4F2 and breast cancer: A study involving 312 participants found that combining POU4F2 and PCDH17 methylation assays achieved a sensitivity of 90.00% and a specificity of 93.96% in detecting BC [18], highlighting the potential of POU4F2 methylation as a biomarker for the non-invasive detection of UC.